199 related articles for article (PubMed ID: 11259457)
1. Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer.
Berberat PO; Friess H; Wang L; Zhu Z; Bley T; Frigeri L; Zimmermann A; Büchler MW
J Histochem Cytochem; 2001 Apr; 49(4):539-49. PubMed ID: 11259457
[TBL] [Abstract][Full Text] [Related]
2. Galectin-1 and galectin-3 in chronic pancreatitis.
Wang L; Friess H; Zhu Z; Frigeri L; Zimmermann A; Korc M; Berberat PO; Büchler MW
Lab Invest; 2000 Aug; 80(8):1233-41. PubMed ID: 10950114
[TBL] [Abstract][Full Text] [Related]
3. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma.
Tang D; Zhang J; Yuan Z; Gao J; Wang S; Ye N; Li P; Gao S; Miao Y; Wang D; Jiang K
PLoS One; 2014; 9(3):e90476. PubMed ID: 24595374
[TBL] [Abstract][Full Text] [Related]
5. Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer.
Ellerhorst J; Troncoso P; Xu XC; Lee J; Lotan R
Urol Res; 1999 Oct; 27(5):362-7. PubMed ID: 10550525
[TBL] [Abstract][Full Text] [Related]
6. Influences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma.
Künzli BM; Berberat PO; Zhu ZW; Martignoni M; Kleeff J; Tempia-Caliera AA; Fukuda M; Zimmermann A; Friess H; Büchler MW
Cancer; 2002 Jan; 94(1):228-39. PubMed ID: 11815981
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression.
Sanjuán X; Fernández PL; Castells A; Castronovo V; van den Brule F; Liu FT; Cardesa A; Campo E
Gastroenterology; 1997 Dec; 113(6):1906-15. PubMed ID: 9394730
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas.
Shimamura T; Sakamoto M; Ino Y; Shimada K; Kosuge T; Sato Y; Tanaka K; Sekihara H; Hirohashi S
Clin Cancer Res; 2002 Aug; 8(8):2570-5. PubMed ID: 12171885
[TBL] [Abstract][Full Text] [Related]
9. galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas.
Cindolo L; Benvenuto G; Salvatore P; Pero R; Salvatore G; Mirone V; Prezioso D; Altieri V; Bruni CB; Chiariotti L
Int J Cancer; 1999 Feb; 84(1):39-43. PubMed ID: 9988230
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stage.
Friess H; Guo XZ; Tempia-Caliera AA; Fukuda A; Martignoni ME; Zimmermann A; Korc M; Büchler MW
J Clin Oncol; 2001 May; 19(9):2422-32. PubMed ID: 11331321
[TBL] [Abstract][Full Text] [Related]
11. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases.
Guo X; Friess H; Graber HU; Kashiwagi M; Zimmermann A; Korc M; Büchler MW
Cancer Res; 1996 Nov; 56(21):4876-80. PubMed ID: 8895737
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer.
Tang D; Gao J; Wang S; Yuan Z; Ye N; Chong Y; Xu C; Jiang X; Li B; Yin W; Miao Y; Wang D; Jiang K
Tumour Biol; 2015 Jul; 36(7):5617-26. PubMed ID: 25725585
[TBL] [Abstract][Full Text] [Related]
13. Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases.
Friess H; Guo XZ; Berberat P; Graber HU; Zimmermann A; Korc M; Büchler MW
Int J Cancer; 1998 Aug; 79(4):349-55. PubMed ID: 9699525
[TBL] [Abstract][Full Text] [Related]
14. COMP is selectively up-regulated in degenerating acinar cells in chronic pancreatitis and in chronic-pancreatitis-like lesions in pancreatic cancer.
Liao Q; Kleeff J; Xiao Y; Di Cesare PE; Korc M; Zimmermann A; Büchler MW; Friess H
Scand J Gastroenterol; 2003 Feb; 38(2):207-15. PubMed ID: 12678339
[TBL] [Abstract][Full Text] [Related]
15. Doc-2/hDab2 expression is up-regulated in primary pancreatic cancer but reduced in metastasis.
Huang Y; Friess H; Kleeff J; Esposito I; Zhu Z; Liu S; Mok SC; Zimmermann A; Büchler MW
Lab Invest; 2001 Jun; 81(6):863-73. PubMed ID: 11406647
[TBL] [Abstract][Full Text] [Related]
16. Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis.
Maruyama H; Kleeff J; Wildi S; Friess H; Büchler MW; Israel MA; Korc M
Am J Pathol; 1999 Sep; 155(3):815-22. PubMed ID: 10487839
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease.
Wang L; Friess H; Zhu Z; Graber H; Zimmermann A; Korc M; Reubi JC; Büchler MW
Clin Cancer Res; 2000 Feb; 6(2):566-71. PubMed ID: 10690540
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers.
Conejo JR; Kleeff J; Koliopanos A; Matsuda K; Zhu ZW; Goecke H; Bicheng N; Zimmermann A; Korc M; Friess H; Büchler MW
Int J Cancer; 2000 Oct; 88(1):12-20. PubMed ID: 10962434
[TBL] [Abstract][Full Text] [Related]
19. Preferential expression of cystein-rich secretory protein-3 (CRISP-3) in chronic pancreatitis.
Liao Q; Kleeff J; Xiao Y; Guweidhi A; Schambony A; Töpfer-Petersen E; Zimmermann A; Büchler MW; Friess H
Histol Histopathol; 2003 Apr; 18(2):425-33. PubMed ID: 12647793
[TBL] [Abstract][Full Text] [Related]
20. Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer.
Zhu Z; Friess H; diMola FF; Zimmermann A; Graber HU; Korc M; Büchler MW
J Clin Oncol; 1999 Aug; 17(8):2419-28. PubMed ID: 10561305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
